Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

dc.contributor.author	Luque, Rafael
dc.contributor.author	Alothman, Zeid A.
dc.contributor.author	Balu, Alina M.
dc.contributor.author	Voskressensky, Leonid
dc.date.accessioned	2021-11-08T13:23:58Z
dc.date.available	2021-11-08T13:23:58Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/10396/22030
dc.description.abstract	A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.	es_ES
dc.format.mimetype	application/pdf	es_ES
dc.language.iso	eng	es_ES
dc.publisher	MDPI	es_ES
dc.rights	https://creativecommons.org/licenses/by/4.0/	es_ES
dc.source	Molecules 26(21), 6738 (2021)	es_ES
dc.subject	Heterogeneous catalysis	es_ES
dc.subject	Waste-to-pharma	es_ES
dc.subject	Furanics	es_ES
dc.subject	APIs	es_ES
dc.title	Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.relation.publisherversion	https://doi.org/10.3390/molecules26216738	es_ES
dc.relation.projectID	Junta de Andalucía. P18-RT-4576	es_ES
dc.rights.accessRights	info:eu-repo/semantics/openAccess	es_ES